Skip to main content
. Author manuscript; available in PMC: 2022 May 26.
Published in final edited form as: Exp Hematol. 2021 Jan 7;95:68–80. doi: 10.1016/j.exphem.2020.12.007

Figure 3.

Figure 3.

Flow cytometry analysis. MFI of HLA-DR was assessed on monocytes (A), and the percentages (%) of CD4+ T cells that were positive for CXCR3 (B), perforin (C), granzyme B (D), PD1 (E) or negative for CD27 (F) were registered. Significant P-values are indicated with * (<0.05), ** (<0.01) or *** (<0.001). CTR: Healthy controls.